J&J Fights For Judgment In Drug Pricing Suit

Law360, New York (August 21, 2007, 12:00 AM EDT) -- Johnson & Johnson has rejected a bid by plaintiffs in the massive antitrust class action over the alleged artificial inflation of the prices of various prescription medications to decide whether to grant treble damages and attorneys' fees before entering a final judgment, arguing that it is “entitled to finality.”

The company said in court documents filed Monday in the U.S. District Court for the District of Massachusetts that it has already been vindicated by U.S. District Judge Patti B. Saris' June 21 ruling which found that...
To view the full article, register now.